We would like to thank all attendees for joining us in Bologna, Italy for this year's annual meeting. Each and every one of you made #CRS2024 one to remember! Stay tuned, we have #CRS2025 updates coming soon. Visit album: 👉https://ow.ly/x8XR50SACZL #deliveryscience #pharma #drugdelivery
Controlled Release Society’s Post
More Relevant Posts
-
Softgel technology with lipid-based drug delivery systems, significantly boosts the bioavailability of new pharmaceutical molecules. Encapsulating active ingredients in a gelatin shell with lipid carriers improves solubility and absorption.
Join us on July 11th for an insightful session titled "Opportunity Cost of Overlooking Softgels: Bioavailability and Release Modulation Insights." Karunakar Sukuru will be presenting at the CRS Conference and Expo in Bologna, Italy. See you there! #CRS2024 #Pharma #Softgels #DrugDelivery https://ow.ly/lY7H50Snq6I
To view or add a comment, sign in
-
-
I am excited and thrilled to speak on this important topic comparing the various bioavailability enhancing technologies with case studies. Overlooking Softgel as a dosage form whether it is for DCS II or IV and considering it as a last resort instead of making it a first choice is proving costly both in terms of time and money especially with new treatment modalities like Protein degraders and other poorly bioavailable molecules. Please join us to see how we BUST various MYTHS with data/ facts on the MOST versatile dosage form ever, (that is Softgel)and see it for yourself to convince..
Join us on July 11th for an insightful session titled "Opportunity Cost of Overlooking Softgels: Bioavailability and Release Modulation Insights." Karunakar Sukuru will be presenting at the CRS Conference and Expo in Bologna, Italy. See you there! #CRS2024 #Pharma #Softgels #DrugDelivery https://ow.ly/lY7H50Snq6I
To view or add a comment, sign in
-
-
Join us at booth 514 at #IFPAC2024 happening right now! Our experts are ready to chat with you and answer all your questions. Come say hello and get to know more about us and our partners Phyllon GmbH and InSilicoTrials. #pharma #continuousmanufacturing #OCT #ParticleSimulation #ProcessControl
To view or add a comment, sign in
-
-
Medicine needs to be "delivered" to organs and cells to have effect - that is as true today as it will be tomorrow. This week Arex Advisor's Nelly Fransén participated in a meeting with the Sweden Drug Delivery Industry Group (SDDIG) in Uppsala. The meeting had a clear focus on collaborating around drug delivery expertise in Sweden - something that we at Arex support whole-heartedly. Would you like to learn more on how we could support you with our drug development know-how? Let's connect! contactATarexadvisor.com. #drugdelivery #formulation #cmc #pharma #regcmc #regulatoryaffairs
To view or add a comment, sign in
-
-
Expanded Access to Medicines | Business Development | Strategic Partnerships | Deal Structuring | Patient Advocate
If you're attending the Expanded Access Programs World Congress next week in London, definitely find time to check out Ana Paula Tediosi's presentation, or catch her during the conference. Ana is a wealth of knowledge when it comes to end to end strategy for all types of access programs (among so many other things)! #earlyaccessprograms, #expandedaccess, #posttrialaccess, #compassionateuse, #clinicaltrials WEP Clinical
Our Head of Expanded Access Strategy Ana Paula Tediosi is looking forward to presenting at the 6th Expanded Access Progammes World Congress 2024 Europe, next week in London. In her presentation, Ana will be providing guidance on navigating asset transitions which involve an EAP. Asset transition is a common challenge for many pharmaceutical companies, and often EAP/CUP and NPP aspects are overlooked, which can create difficulties for the teams involved. If you will be at the event, make sure you check out Ana’s presentation on day 1 at 11.30am. #expandedaccess #compassionateuse #WithEveryPatient #TreatmentAccessSolutions
To view or add a comment, sign in
-
-
A great snapshot into last week's #MedComms Forum hosted by NetworkPharma Ltd and sponsored by aps Events & Media. It was wonderful to see so many faces (old and new). Here are some of my key personal highlights: Session 1 - Event Landscapes, Insights, and Demands 💻 Face-to-face engagement is important; however, virtual and hybrid meetings are often more inclusive for those unable to attend in-person. 🤝 Medical societies need to engage with new audiences and reformulate sponsorship policies to focus on partnerships. 🎯 The industry needs to focus on key impact indicators as well as key performance indicators to provide maximal benefit to society. Session 2 - Compliance, 2024 Code 📜 Navigating national codes can be challenging, with compliance barriers (and company risk tolerance) often hindering meaningful patient engagement. 🗞 The updated ABPI code of conduct is expected in the 4th quarter of 2024, with a 3-month transition period planned upon publication. Session 3 - Patient Inclusion 🎙 Meaningful patient engagement can be realised when patients are involved in the planning, delivery, evaluation, and leadership of scientific congresses. 🔗 Congress organisers should consider integrated patient tracks and accessibility when planning meetings to ensure maximal impact for everyone involved. 💼 Education, networking, and collaboration are key reasons why patients want to attend scientific congresses. #MedicalCommunications #MedicalAffairs #MedAffairs #Pharma #PatientEngagement #PatientInvolvement #PatientsInvolved #PatientAdvocacy #PatientsIncluded #IntegratedPatientEngagement
Following our MedComms Forum update last week, check out our highlights video from the day! #MedComms #Pharma #TechnicalProduction
To view or add a comment, sign in
-
Facilitándole un equipo de consultores que le ayuden a optimizar sus líneas de produción y a eliminar reclamaciones de sus clientes, con el único objetivo de incrementar su imagen de marca
Listen in to this webinar where Tracy Nasarenko (GS1) and Joe Lipari (Systech) spoke about how standards play a crucial role in identifying products and their locations. Download now: https://bit.ly/3Sv15jB #Pharma #Traceability #GS1 #Systechone
To view or add a comment, sign in
-
Solutions Consultants Manager at Markem-Imaje | MBA | Fostering Innovation & Growth in Packaging Intelligence through Strategic Leadership and Team Empowerment
Listen in to this webinar where Tracy Nasarenko (GS1) and Joe Lipari (Systech) spoke about how standards play a crucial role in identifying products and their locations. Download now: https://bit.ly/3Sv15jB #Pharma #Traceability #GS1 #Systechone
Systech International on LinkedIn: Future of Traceability in Pharma
share.postbeyond.com
To view or add a comment, sign in
-
A real transformation in drug prices in US (#IRA) making healthcare more accessible, affordable and available. We are entering a new era of regulated drug pricing similar to EU and Asian countries. Pharma Cos must adapt their strategies to the new negotiating landscape. 💡 Dive into our study, which showcases the pivotal IRA provisions and the implications for pharmaceutical companies and patients: ➡ https://lnkd.in/d2wbv3bn #RolandBerger ✍ Filip Conic Matthias Bünte Atsushi Kiyoizumi Thilo Kaltenbach Michael Baur Prof. Dr. Torsten Henzelmann Julien Gautier Anne Moore, PhD Hans Nyctelius Koen Besteman Kai Balder Stephan Fath Marco Bühren Yoshihiro Suwa Aditya Agarwal Lennart Boesch Omer Saka Sara Barada Salil Churi
To view or add a comment, sign in
-
It was an interesting week at RDD, meeting the industry peers, partners and experts and discussing the latest developments in the pMDI space and its future path for various geographies #RDDUSA #RespiratoryDrugDelivery #Tucson #pMDI
As one of the few manufacturers of Pharma grade HFA 134a/P worldwide, it was a pleasure for our team to exhibit at RDD USA. We thank our wonderful customers, associates, and friends for dropping by our booth. It was a great show, and we can’t wait to be back next year! Hemango Gupta SIBU SATHYASEELAN Arpita Singh #RDD2024 #pharma #SRF50
To view or add a comment, sign in
-